ZFIN ID: ZDB-PUB-100302-14
Scl isoforms act downstream of etsrp to specify angioblasts and definitive hematopoietic stem cells
Ren, X., Gomez, G.A., Zhang, B., and Lin, S.
Date: 2010
Source: Blood   115(26): 5338-5346 (Journal)
Registered Authors: Gomez, Gustavo, Lin, Shuo
Keywords: none
MeSH Terms:
  • Animals
  • Basic Helix-Loop-Helix Transcription Factors/analysis
  • Basic Helix-Loop-Helix Transcription Factors/metabolism*
  • Core Binding Factor Alpha 2 Subunit/metabolism
  • Hematopoiesis*
  • Hematopoietic Stem Cells/cytology*
  • Hematopoietic Stem Cells/metabolism
  • Neovascularization, Physiologic
  • Protein Isoforms/analysis
  • Protein Isoforms/metabolism
  • Proto-Oncogene Protein c-fli-1/metabolism
  • Proto-Oncogene Proteins/analysis
  • Proto-Oncogene Proteins/metabolism*
  • Zebrafish/embryology
  • Zebrafish/metabolism*
  • Zebrafish Proteins/analysis
  • Zebrafish Proteins/metabolism*
PubMed: 20185582 Full text @ Blood
Recent lineage studies suggest that hematopoietic stem cells (HSCs) may be derived from endothelial cells. However, the genetic hierarchy governing the emergence of HSCs remains elusive. We report here that zebrafish etsrp, which is essential for vascular endothelial development, also plays a critical role in the initiation of definitive hematopoiesis by controlling the expression of two scl isoforms (scl-alpha and scl-beta) in angioblasts. In etsrp morphants, which are deficient in endothelial and HSC development, scl-alpha alone partially rescues angioblast specification, arterial-venous differentiation and the expression of HSC markers, runx1 and c-myb, while scl-beta requires angioblast rescue by fli1a to restore runx1 expression. Interestingly, when Vegf signaling is inhibited, HSC marker expression can still be restored by scl-alpha in etsrp morphants, while the rescue of arterial ephrinb2a expression is blocked. Furthermore, both scl isoforms partially rescue runx1 but not ephrinb2a expression in embryos deficient in Vegf signaling. Our data suggest that downstream of etsrp, scl-alpha and fli1a specify the angioblasts, while scl-beta further initiates HSC specification from this angioblast population, and that Vegf signaling acts upstream of scl-beta during definitive hematopoiesis.